BackNektar Therapeutics Overview

Nektar Therapeutics Operating Income

Operating Income for NKTR.

Quarterly Operating Income

$-39054000.00
12.31% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-134761000.00
33.4% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)